All Journal Guides

Journal Guide

Trends in Molecular Medicine Impact Factor 13.8: Publishing Guide

Translating molecular biology to medical practice and human health

13.8

Impact Factor (2024)

~10-20% (primarily invited reviews)

Acceptance Rate

~60-90 days median

Time to First Decision

What Trends Mol. Med. Publishes

Trends in Molecular Medicine published by Cell Press covers translational medicine and molecular approaches to disease. With a publisher-reported impact factor of 13.8, the journal emphasizes reviews connecting molecular biology to clinical medicine. The journal publishes expert reviews translating discovery to practice. Critically: TRMM is primarily invitation-based for reviews, though exceptional unsolicited submissions can still be considered. The journal values reviews synthesizing molecular mechanisms and clinical translation.

  • Molecular disease mechanisms: pathophysiology through molecular lens
  • Drug targets: mechanism-based target identification and validation
  • Therapeutic strategies: molecular approaches to treatment
  • Personalized medicine: molecular diagnostics enabling precision treatment
  • Disease subtypes: molecular classification of diseases and patient stratification
  • Resistance mechanisms: molecular basis of therapeutic resistance
  • Biomarkers: molecular markers predicting disease or treatment response
  • Emerging therapies: novel molecular therapeutic approaches

Editor Insight

TRMM publishes reviews synthesizing molecular mechanisms and clinical translation. We seek expert-authored reviews connecting basic science discoveries to medical practice.

What Trends Mol. Med. Editors Look For

Authoritative synthesis of molecular mechanisms in disease and treatment

Expert reviews connecting molecular biology to clinical outcomes. Comprehensive coverage of disease mechanism and therapeutic approaches.

Integration of basic and clinical science

Reviews bridging molecular discovery with clinical application. Show how molecular understanding enables therapy.

Critical evaluation of competing molecular mechanisms

Discuss different models and mechanistic interpretations. Where is consensus? Where is uncertainty?

Clear articulation of therapeutic implications

Show how molecular understanding guides treatment. What molecular targets matter? What mechanisms drive clinical outcomes?

Future directions and emerging approaches

Identify gaps in understanding and promising new molecular approaches. Guide research forward.

Why Papers Get Rejected

These patterns appear repeatedly in manuscripts that don't make it past Trends Mol. Med.'s editorial review:

Literature review without critical synthesis or clinical integration

Reviews should synthesize and integrate, not just catalog. Connect molecular biology to patient outcomes.

Focus exclusively on mechanisms without clinical applications

TRMM expects translation. Show clinical relevance and therapeutic potential.

Incomplete coverage of field or ignoring competing models

Authoritative reviews address major mechanisms and interpretations.

No discussion of therapeutic targets or clinical implications

Show how molecular understanding enables treatment or patient stratification.

Overly narrow scope without broader disease context

Reviews should provide context within broader disease or therapeutic landscape.

Does your manuscript avoid these patterns?

The quick diagnostic reads your full manuscript against Trends Mol. Med.'s criteria and flags the specific issues most likely to cause rejection.

Run Free Readiness Scan →

Insider Tips from Trends Mol. Med. Authors

Editor pre-approval important for unsolicited reviews

Contact editor with proposed topic and expertise before writing unsolicited review.

Emerging molecular therapies and novel approaches valued

Reviews synthesizing new molecular therapeutic strategies increasingly competitive.

Molecular resistance mechanisms increasingly prominent

Understanding resistance mechanisms and overcoming resistance increasingly important.

Precision medicine and molecular diagnostics trending

Molecular approaches enabling patient stratification and treatment selection.

Recent clinical advances and FDA approvals increase relevance

Reviews synthesizing recent therapeutic breakthroughs more timely and competitive.

The Trends Mol. Med. Submission Process

1

Pre-submission inquiry (strongly recommended for unsolicited)

Before writing

Contact editor with review topic, expertise, outline, and clinical significance justification.

2

Manuscript preparation

Prep

5,000-8,000 words. Comprehensive mechanism discussion, clinical integration, critical evaluation, therapeutic implications, future directions.

3

Submission via Cell Press system

Day 0

Submit through Elsevier/Cell Press system. Include cover letter establishing expertise and review timeliness.

4

Editorial assessment

1-2 weeks

Editor assesses review quality, clinical relevance, timeliness. Unsolicited reviews face high bar.

5

Revision and publication

Revision: 2-4 weeks

Typically one round of minor revisions. Publication 2-4 weeks after acceptance.

Trends Mol. Med. by the Numbers

2024 Impact Factor(Elsevier journal page)13.8
Acceptance rate~10-20% (mostly invited)
Desk rejection rate~60-70%
Median first decision~75 days
Article typeReviews primarily
PublisherCell Press/Elsevier
Founded1995

Before you submit

Trends Mol. Med. accepts a small fraction of submissions. Make your attempt count.

The pre-submission diagnostic runs a live literature search, scores your manuscript section by section, and gives you a prioritized fix list calibrated to Trends Mol. Med.. ~30 minutes.

Article Types

Review

5,000-8,000 words

Molecular medicine synthesis (invitation preferred, rare unsolicited)

Landmark Trends Mol. Med. Papers

Papers that defined fields and changed science:

  • Molecular cancer mechanisms (various) - oncology translation
  • Drug resistance and overcoming resistance (2010s+) - therapeutic challenges
  • Personalized medicine and stratification (2010s+) - precision treatment
  • Novel therapeutic targets (various) - drug development guidance

Preparing a Trends Mol. Med. Submission?

Get pre-submission feedback from reviewers who've published in Trends Mol. Med. and know exactly what editors look for.

Run Free Readiness Scan

Need expert depth? Human review from $1,000

NDA-protected
Confidential

Primary Fields

Molecular MechanismsDrug TargetsPersonalized MedicineBiomarkersTherapeutic Resistance